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Although carcinoembryonic antigen-related cell
adhesion moclecule-1 (CEACAM1) is an activation
marker for neutrophils and delays neutrophil
apoptosis, the role of CEACAM1 in granulopoiesis
and neutrophil-dependent host immune responses
has not been investigated. CEACAM1 expression
correlated with granulocytic differentiation, and
Ceacam1/ mice developed neutrophilia because
of loss of the Src-homology-phosphatase-1 (SHP-1)-
dependent inhibition of granulocyte colony-stimu-
lating factor receptor (G-CSFR) signal transducer
and activator of transcription (Stat3) pathway pro-
vided by CEACAM1. Moreover, Ceacam1/ mice
were hypersensitive to Listeria Monocytogenes
(LM) infection with an accelerated mortality. Reintro-
duction of CEACAM1 into Ceacam1/ bone marrow
restored normal granulopoiesis and host sensitivity
to LM infection, while mutation of its immunorecep-
tor tyrosine-based inhibitory motifs (ITIMs) abro-
gated this restoration. shRNA-mediated reduction
of Stat3 amounts rescued normal granulopoiesis,
attenuating host sensitivity to LM infection in
Ceacam1/ mice. Thus, CEACAM1 acted as a coin-
hibitory receptor for G-CSFR regulating granulopoie-
sis and host innate immune response to bacterial
infections.
INTRODUCTION
Neutrophils, the largest subset of granulocytes, are the first line
of defense against various infections caused by bacteria, fungi,
and parasites. Neutrophils traffic into infected tissues and clear
pathogens while secreting proinflammatory cytokines that may
cause tissue damage (Nathan, 2006). Because of their short
life span, hematopoietic stem cells continuously produce granu-
locytes at a basal or emergent stage, requiring a strict regulation
of granulopoiesis (Christopher and Link, 2007).
Granulocyte-colony stimulating factor receptor (G-CSFR) is
the master regulator of granulopoiesis because both G-CSF620 Immunity 33, 620–631, October 29, 2010 ª2010 Elsevier Inc.and G-CSFR genetically ablated mice develop severe neutrope-
nia (Lieschke et al., 1994; Liu et al., 1996). Binding of G-CSF to
G-CSFR activates a signaling cascade, including phosphoryla-
tion of signal transducer and activator of transcription (Stat3),
a key regulator of basal and emergent granulopoiesis (Avalos,
1996). Similar with its function as a proproliferative oncogene
in tumor (Yu et al., 2009), Stat3 also promotes mitogenic
signaling to facilitate neutrophil production in response to
G-CSF (Avalos, 1996), and hyperactive Stat3 induces enhanced
granulopoiesis (Croker et al., 2004). Consistent with the finding
that Stat3 antagonizes Stat1 and Stat5 activation in T helper
cell differentiation and tumor environment (Welte et al., 2003)
G-SCF only weakly activates Stat1 and Stat5 in Stat3-proficient
models (Avalos, 1996; Chakraborty et al., 1996; Tian et al., 1994).
However, once the antagonizing function of Stat3 is lost in Stat3
conditional genetically ablatedmice, hyperactive Stat1 compen-
sates for Stat3 and becomes an alternative G-CSFR down-
stream pathway, resulting in neutrophilia (Lee et al., 2002). Taken
together, Stat3 expression and activation need to be properly
controlled for normal granulopoiesis. In addition, loss of b2-in-
tegrin or leukocyte-endothelial (LE)-selectin induces neutrophilia
because of elevated basal amounts of G-CSF and IL-17 (Forlow
et al., 2001; Stark et al., 2005), suggesting a noncellular autono-
mous feedback mechanism, while loss of CXC-chemokine
receptor-4 (CXCR-4) affects granulopoiesis in a cellular autono-
mous fashion (Eash et al., 2009). The possibility that inhibitory
coreceptors may also regulate G-CSFR-dependent granulopoi-
esis has not been investigated.
In this respect, CEACAM1 is a likely candidate based on its
high expression on neutrophils and its known role as an inhibitory
coreceptor in the immune system (Gray-Owen and Blumberg,
2006). The CEACAM1 molecule consists of cytoplasmic,
transmembrane, and extracellular domains. The extracellular
domains comprise a membrane distal IgV- like N-domain, fol-
lowed by a variable number of IgC-like domains. The N-domain
mediates homophilic ligation with other CEACAM1 molecules or
heterophilic ligation with other CEA family members (Gray-Owen
and Blumberg, 2006). Both human and murine CEACAM1 tran-
scripts undergo alternative splicing, generating 11 human and
four murine isoforms (Gray-Owen and Blumberg, 2006).
The CEACAM1 long form has two ITIMs in its cytoplasmic
domain, which, upon phosphorylation, recruit Src homology
domain-containing protein-tyrosine phosphatases SHP-1 and -2,
which, in turn, suppress signal transduction of associated
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(Gray-Owen and Blumberg, 2006). In activated T cells, recruit-
ment of SHP-1 by CEACAM1 downregulates TCR signaling by
targeting Zap-7 (Chen et al., 2008) and IL-2R signaling (Chen
and Shively, 2004). Overexpression of CEACAM1 long forms in
T cells prevents inflammatory bowel disease (IBD) in a murine
colitis model (Nagaishi et al., 2006). In germinal B cells, anti-
IgM induces CEACAM1 phosphorylation, SHP-1 recruitment,
and subsequent suppression of PI3-K signaling, leading to
potentiated activation-induced cell death (AICD) (Lobo et al.,
2009). Although these studies demonstrate how CEACAM1
regulates immune effector cell function, the possibility that
CEACAM1 may regulate immune cell development has not
been addressed. Although CEACAM1 plays a role in activation
and apoptosis of neutrophils (Singer et al., 2002, 2005), its role
in granulopoiesis and neutrophil-dependent innate immune
response in infectious models has not been investigated.
Here, we use retroviral transduction and bone marrow recon-
stitution to reintroduce CEACAM1, ITIM-mutated CEACAM1 into
Ceacam1/ bone marrow (BM), or to normalize p-Stat3
amounts in Ceacam1/ BM and study the effects on granulo-
poiesis and innate immune response. Our results demonstrate
that CEACAM1 regulates myeloid development by functioning
as a coinhibitory receptor of G-CSFR through ITIM and SHP-1,
leading to downregulation of downstream Stat3 activation, and
the absence of CEACAM1 results in elevated G-CSFR-Stat3
signaling and neutrophilia, which, in turn, adversely affects the
innate immune response to pathogenic bacteria.Figure 1. CEACAM1 Expression Correlates with Granulocytic
Lineage Differentiation
(A) Quantification of CEACAM1 surface expression amount of PB neutrophils
(Ly-6G+CD11b+), monocytes (Ly-6C+CD11b+), and macrophages (Ly-6C,
CD11b+, F4/80+) (left panel, NC, negative control) and a comparison of CEA-
CAM1 expression on BM neutrophils (BMN) and PB neutrophils (PBN) from
WTmice (right panel) by flow cytometry shown bymean fluorescence intensity
(MFI).
(B) Immunoblot showing the CEACAM1 expression by anti-murine CEACAM1
(CC1) in Lin BM cells from WT and Ceacam1/ mice.
(C) Flow-cytometric quantification of CEACAM1 expression amounts on
GMPs, CMPs, andMEPs, respectively, gated on the LinSca-1c-Kit+ fraction
in cells.
(D) Q-RT PCR showing the CEACAM1 isoform amounts in neutrophils and Lin
BM cells (mean ± SD, n = 6).
Data are representative of three experiments (A–C).RESULTS
CEACAM1 Is a Granulocytic Lineage Differentiation
Marker
Neutrophils, monocytes, and macrophages from wild-type (WT)
mice expressed high amounts of CEACAM1, with neutrophil
expression found at a significantly higher amount compared to
monocytes and macrophages (Figure 1A). In addition, peripheral
blood neutrophils (PBNs) that are more mature than bone
marrow neutrophils (BMNs) expressed a slightly higher amount
of CEACAM1 on the cell surface than BMNs. We also examined
the expression of CEACAM1 on lineage-negative bone marrow
(Lin BM) cells by immunoblot (Figure 1B) and flow-cytometric
analysis (Figure 1C). Although these progenitor cells expressed
a relatively lower amount of CEACAM1 compared to the mature
innate immune cells, granulocyte-monocyte progenitors (GMPs)
that specifically give rise to granulocytes and monocytes
expressed higher amounts of CEACAM1 than common myeloid
precursors (CMPs) and megakaryocyte-erythrocyte precursors
(MEPs) (Figure 1C). These results indicate that from the
early progenitor stage to the final effector stage, cell-surface
CEACAM1 amounts correlate with granulocytic lineage differen-
tiation.We also compared the long and short forms of CEACAM1
by quantitative real-time PCR using CEACAM1 long form and
short form specific primers, showing that neutrophils and Lin
BM cells expressed both the long and short forms of CEACAM1
at the mRNA level (Figure 1D) with a general preference for the
long form (in neutrophils, the Long:Short [L:S] ratio was about
1.76; in Lin BM cells, the L:S ratio was about 1.41).Immunity 33, 620–631, October 29, 2010 ª2010 Elsevier Inc. 621
Figure 2. GeneticAblationofCEACAM1Leads toDysregulatedGran-
ulopoiesis Because of Neutrophil Progenitor Cell Hyperproliferation
(A) Representative flow cytometric analysis showing Ly-6G+, CD11b+ neutro-
phil population in BM, spleen, peripheral blood, and liver from WT and
Ceacam1/ mice (KO). Total neutrophils shown in bar graphs (mean ± SEM,
n = 12 mice).
(B) Methylcellulose colony formation assays of 13 105 BM cells in response to
varied concentrations of G-CSF (mean ± SEM, n = 6 mice).
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622 Immunity 33, 620–631, October 29, 2010 ª2010 Elsevier Inc.Genetic Ablation of CEACAM1 Leads to Dysregulated
Granulopoiesis Because of Neutrophil Progenitor
Cell Hyperproliferation
Because CEACAM1 is expressed on neutrophil progenitors
(Figures 1B–1D) and is a known inhibitory coreceptor on acti-
vated lymphocytes (Gray-Owen and Blumberg, 2006), we
hypothesized that granulocytic development and production
would be affected in Ceacam1/ mice. In contrast to WT
C57BL/6 mice, Ceacam1/ mice spontaneously developed
systemic neutrophilia as manifested by the dramatically higher
numbers of the Ly-6G+CD11b+ population in BM, peripheral
blood (PB), spleen, and liver (Figure 2A). This dysregulated gran-
ulopoiesis could be explained by an accumulation of neutrophils
with a slower turnover rate or an augmented neutrophil produc-
tion frommyeloid progenitor cells. To test the first possibility, we
utilized the in vitro spontaneous apoptosis assay (Johnnidis
et al., 2008) and found that Ceacam1/ neutrophils underwent
normal or slightly faster apoptosis than WT ones (Figures S1A–
S1B available online). To test the second possibility, we
assessed neutrophil progenitor cell proliferation in themethylcel-
lulose colony formation assay. G-CSF-treated Ceacam1/ BM
produced 2-fold more neutrophil colonies than WT (Figure 2B).
Ceacam1/ BM had 1.6 times the number of GMPs than WT
(Figure 2C). When the proliferative capacity of the GMPs was
measured by bromodeoxyuridine (BrdU) incorporation, there
was a higher ratio of BrdU+ GMPs in Ceacam1/ mice than
the WT (Figure 2D). Since there was no obvious difference in
BrdU incorporation of WT or Ceacam1/ neutrophils (data not
shown), the observed neutrophilia in Ceacam1/ mice does
not result from proliferation of neutrophils. In G-CSF-induced
emergent granulopoiesis (Croker et al., 2004; Roberts et al.,
1997) in WT mice, bone marrow neutrophil and peripheral blood
counts were 21 3 106 and 15 3 105/ml, respectively, while in
G-CSF-treated Ceacam1/ mice, enhanced granulopoiesis
was observed (BMN 95 3 106, PBN 112 3 105/ml) (Figure 2E).
These results suggest that CEACAM1 negatively regulates
G-CSF-mediated basal (homeostatic) and emergent granulopoi-
esis and that genetically ablating CEACAM1 leads to neutrophilia
because of neutrophil progenitor cell hyperproliferation.
Ceacam1–/– BM Cells Act Autonomously,
and CEACAM1 Regulation of Progenitor
Cells Is Granulocytic Lineage Specific
b2-integrin or LE-selectin genetically ablated mice develop neu-
trophilia in a nonautonomous feedback mechanism (Forlow
et al., 2001; Stark et al., 2005). To study if thismechanism applies
to CEACAM1, reverse BM reconstitution was performed in which
we transplantedWT BM cells into lethally irradiatedCeacam1/(C) Left: flow-cytometric analysis of myeloid progenitor cell populations of WT
and Ceacam1/ mice (KO). Right: overall number of progenitors per BM
sample from one mouse (mean ± SEM, n = 8 mice).
(D) Flow-cytometric quantification of in vivo BrdU incorporation of GMPs from
WT and Ceacam1/ mice 24 hr post-BrdU injection (NC, negative control;
percentage indicates BrdU+ populations).
(E) BM neutrophil (BMN) and peripheral blood neutrophil (PBN) numbers in WT
and Ceacam1/ mice after G-CSF treatment are represented in graphs
(mean ± SEM, n = 6 mice). *p < 0.05; **p < 0.005; ***p < 0.0001 (two-tailed
Student’s t tests).
Data are representative of three experiments (C and D).
Figure 3. CEACAM1 Downregulates
G-CSFR Stat3 Signaling
(A) Immunoblot analysis of the p-Tyr, G-CSFR,
SHP-1, and CEACAM1 in WT and Ceacam1/
(KO) Lin BM cells with or without G-CSF treat-
ment (40 ng/ml) after IP with CC1 antibody.
(B) Immunoblot analysis of p-Stat3 and Stat3 in
WT andCeacam1/ LinBMcells with or without
G-CSF treatment (40 ng/ml). Numbers below
lanes indicate the ratio of p-Stat3 to GAPDH.
(C) Flow-cytometric analysis of intracellular stain-
ing of p-Stat3 and Stat3 in WT and KO GMPs with
or without G-CSF treatment (40 ng/ml).
(D) Immunoblot analysis of C-Myc and Cyclin D1
in WT and Ceacam1/ Lin BM cells with or
without G-CSF treatment (40 ng/ml).
(E) Q-RT PCR showing the Cyclin D1 and C-Myc
mRNA amounts in sorted WT and Ceacam1/
GMPs.
Data are representative of three experiments (A–E).
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recipients. Ceacam1/ BM cells act independently because
WT recipients receiving Ceacam1/ BM cells developed neu-
trophilia while Ceacam1/ recipients that received WT BM cells
did not (Figure S1C).
To test if CEACAM1’s regulation on progenitor cells is granulo-
cytic lineage specific, we carried out a BM competition assay in
which equivalent amounts of BM cells from Ceacam1/
C57BL/6 (CD45.2) and congenic WT C57BL/6 (CD45.1) mice
were coinjected into lethally irradiated WT C57BL/6 recipients.
We found that 81% of the BMNs expressed CD45.2, while for BM
Bcells, the ratioofCD45.1+:CD45.2+wasclose to 1:1 (FigureS1D),
a result consistent with our observation thatCeacam1/mice did
not have abnormal numbers of BM or spleen B or T cells (data not
shown).Wealso found that thereweremoreCD45.2+ (Ceacam1/
BM derived) GMP populations than CD45.1+, confirming
CEACAM1 regulates early granulopoiesis autonomously (data not
shown). In methylcellulose assays, Ceacam1/ and WT BMImmunity 33, 620–631,gave rise to similar numbersof erythrocyte,
megakaryocyte, or macrophage colonies
(Figure S2E). We conclude that the effect
of CEACAM1 on progenitor cells is granu-
locytic lineage specific.
CEACAM1 Downregulates G-CSFR
Stat3 Signaling
Since CEACAM1 acts as a coinhibitory
receptor for many receptors (Gray-Owen
and Blumberg, 2006) and G-CSFR is the
central mediator of granulopoiesis (Avalos,
1996), we hypothesized that CEACAM1
negatively regulates G-CSFR signaling.
Treatment of WT Lin BM cells with
G-CSF induced significant tyrosine phos-
phorylation of CEACAM1, while IP of
CEACAM1co-IPedG-CSFR in theG-CSF-
treated Lin BM cells, indicating that
CEACAM1 is physically associated with
G-CSFRafterG-CSFtreatment (Figure3A).
Accordingly, the amount of p-Stat3 in Ceacam1/ Lin BM cells
was 2-fold higher than in the WT Lin BM cells after G-CSF treat-
ment (Figure 3B), as well as increased amounts of p-Stat3 in
Ceacam1/ GMPs as measured by intracellular staining (Fig-
ure 3C). Analysis of other G-CSFR downstream molecules ex-
hibited no difference of p-Stat1, p-Stat5, p-Akt, or p-Erk1/2
betweenWTandCeacam1/ LinBMcells afterG-CSF treatment
(Figure S2). The proproliferative Stat3 target genes, CyclinD1 and
C-Myc, (Yu et al., 2009), were induced at a higher amount in Lin
BM cells after G-CSF treatment (Figure 3D). Also, sorted
Ceacam1/ GMPs transcribed more CyclinD1 and C-Myc
mRNAafterG-CSF treatment (Figure3E). Thus, elevatedStat3acti-
vation is primarily responsible for neutrophilia inCeacam1/mice.
CEACAM1 Inhibits G-CSFR-Stat3 Signaling and
Granulopoiesis through ITIM Recruitment of SHP-1
The CEACAM1 long form contains two ITIMs and is the isoform
that mediates an SHP-1-dependent suppressive signal uponOctober 29, 2010 ª2010 Elsevier Inc. 623
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Although WT Lin BM cells expressed both long and short iso-
form transcripts of CEACAM1, we assumed that the inhibitory
effect of CEACAM1 on granulopoiesis and G-CSFR signaling is
ITIM-SHP-1 dependent. To test this hypothesis, we reintroduced
CEACAM1 long form (CEACAM1-2L, CEACAM1-4L), short form
(CEACAM1-2S, CEACAM1-4S), and ITIM tyrosine mutated long
form (CEACAM1-2Lm and CEACAM1-4Lm) into Ceacam1/
BM stem cells and transplanted them into lethally irradiated
Ceacam1/ recipients (Figures S3A–S3C). Two months after
reconstitution, we found that CEACAM1 long forms, but not
the short forms, restored normal neutrophil populations (Figures
4A and 4B), normal GMP populations (data not shown), and
normal p-Stat3 amounts (Figure 4C). Moreover, mutating the
tyrosines in the ITIMs prevented this restoration (Figures 4A–4C).
We carried out IP analysis to determine if the physical interac-
tion between CEACAM1 andG-CSFR is ITIM-SHP-1 dependent.
Interestingly, G-CSF induced tyrosine phosphorylation of both
the CEACAM1 long form and short form (the murine CEACAM1
short forms have a tyrosine site in their cytoplasmic domains)
(Figure 4D). As expected, there was no tyrosine phosphorylation
of CEACAM1 in the Lin BM cells isolated from Ceacam1/
mice reintroduced with CEACAM1-2Lm, CEACAM1-4Lm, or
empty vector (Figure 4D). Consistent with our hypothesis,
G-CSFR was pulled down by anti-CEACAM1 upon G-CSF treat-
ment only in the Lin BM cell lysates isolated from Ceacam1/
mice reintroducedwith CEACAM1 long form (Figure 4D).We also
demonstrated that CEACAM1 associates with SHP-1 upon
G-CSF treatment in WT Lin BM cells (Figure 3A) or Lin BM
cells isolated from Ceacam1/ mice receiving CEACAM1-2L
or CEACAM1-4L (Figure 4D), but not in Lin BM cells recovered
from Ceacam1/mice receiving CEACAM1-2S, -4S, CEACM1-
2Lm, -4Lm, or empty vector (Figure 4D). Thus, CEACAM1-SHP-1
association depends on the presence of the ITIMs in CEACAM1
long forms. In WT Lin BM cells, SHP-1 also directly associated
with G-CSFR as shown by IPs using anti-SHP-1 antibody
(Figure 4E), leading to dephosphorylation of G-CSFR
(Figure 4F). Notably, the SHP-1-G-CSFR association was abro-
gated in Ceacam1/ Lin BM cells, revealing the indispensable
role of CEACAM1 in recruiting SHP-1 to dephosphorylate
G-SCFR. Lastly, the dependency of SHP-1 was confirmed by
shRNA-mediated reduction of SHP-1 in WT mice, a treatment
that caused augmented granulopoiesis associated with elevated
G-CSFR-Stat3 signaling (Figures S3D–S3G). Therefore, we
conclude that the CEACAM1 downregulation of the G-CSFR-
Stat3 pathway depends on its ITIMs and recruitment of SHP-1.
Modulation of CEACAM1 Regulates Host Immune
Response to LM Infection
To study the physiological impact of the enhanced granulopoie-
sis of Ceacam1/ mice, they were infected with Listeria Mono-
cytogenes (LM), an infectious model in which neutrophils play an
indispensable role in clearance during the early stages of infec-
tion (Eash et al., 2009; Nathan, 2006; Zhu et al., 2009). Although
enhanced bacteria clearance and prolonged survival of
Ceacam1/ mice because of their neutrophilia was a likely
outcome, it is also possible that loss of negative signaling by
CEACAM1 and neutrophilia could lead to enhanced tissue
damage and proinflammatory cytokine production. Indeed,624 Immunity 33, 620–631, October 29, 2010 ª2010 Elsevier Inc.Ceacam1/ mice died dramatically faster than the WT mice;
in fact, almost all Ceacam1/ mice died within 7 days, while
the WTmice had a 40% survival rate, even at day 12 (Figure 5A).
Bacterial colonies in either the liver or spleen of Ceacam1/
mice 3 days postinfection were fewer compared with WT,
showing that Ceacam1/ mice had improved bacterial clear-
ance (Figure 5B). Therefore, the accelerated mortality was prob-
ably not because of failure of bacterial clearance in Ceacam1/
mice. Because it was also possible that lack of CEACAM1
affects neutrophil antibacterial functions, an in vitro bacterial
killing assay was performed. In this assay, there was no signifi-
cant difference between Ceacam1/ and WT neutrophils (Fig-
ure S4A). Importantly, Ceacam1/ neutrophils also performed
normally in actin-cytoskeleton rearrangement and migration
assays (Figures S4B–S4C). Therefore, the improved bacterial
clearance in Ceacam1/ mice was not because of abnormal
migration or an abnormal bacterial killing function of
Ceacam1/ neutrophils, but instead was because of increased
neutrophil numbers in Ceacam1/ mice. However, the im-
proved bacterial clearance in infected Ceacam1/ mice was
accompanied by severe tissue damage and necrosis in the liver
(Figure 5C, quantified in Figure S4D), likely caused by neutro-
phils. Indeed, significantly more neutrophils were recovered in
infected Ceacam1/ livers than in the WT ones (Figure 5D). In
addition, in LM infected Ceacam1/ mice, serum amounts of
interleukin-1b (IL-1b), which was in the range associated with
endotoxic shock (Greten et al., 2007), and IL-6, keratinocyte-
derived chemokine (KC), tumor necrosis factor-a (TNF-a) to a
lesser degree, were higher compared to WT mice (Figure 5E).
To further elucidate the cause of the elevated proinflammatory
cytokine amounts in vivo, we analyzed whether CEACAM1 regu-
lates cytokine production on a cellular basis.We examined neutro-
phils and macrophages, two major cellular sources of cytokine
production during early days postinfection. When cells were
stimulated in vitro with lipopolysaccharide (LPS), a toll-like
receptor 4 (TLR4) ligand, or peptidoglycan (PGN), a TLR2 ligand,
no significant difference in IL-1b, TNF-a, IL-6, and KC production
was observed between WT and Ceacam1/ macrophages (Fig-
ure S5A). Interestingly, Ceacam1/ neutrophils produced signifi-
cantly more IL-1b (data not shown) but similar amounts of TNF-a,
IL-6, and KC compared with WT neutrophils (Figure S5B). We
conclude that while loss of CEACAM1 significantly affects neutro-
phil IL-1b production, there was no obvious effect on the produc-
tion of other proinflammatory cytokines. Also, loss of CEACAM1
does not seem to affect macrophage production of proinflamma-
torycytokines.Basedon the invitropercell basedcytokineproduc-
tionprofile,we inferred that thesignificantlyhigherserumamountof
IL-1b inCeacam1/ mice after LM infection was because of both
elevated neutrophils and elevated IL-1b production capacity by
individual Ceacam1/ neutrophils, while the moderately higher
amounts of TNF-a, IL-6, and KC were likely because of increased
neutrophil numbers only in Ceacam1/ mice.
Because neutrophilia in WT mice can be induced by G-CSF
treatment (Croker et al., 2004; Roberts et al., 1997), it was possible
to examine the effects of increased neutrophils on cytokine
production during LM infection. Indeed, in response to LM infec-
tion, the G-CSF-treated WT mice, which have comparable
numbers of bone marrow and peripheral blood neutrophils as
the Ceacam1/ mice without G-CSF treatment (Figure 2E),
Figure 4. CEACAM1 Inhibits G-CSFR-Stat3 Signaling and Granulopoiesis through ITIM Recruitment of SHP-1
(A) Experimental design for retroviral transduction and BM reconstitution (top) and representative flow-cytometric analysis showing Ly-6G+,CD11b+ neutrophil
population in BM and peripheral blood in Ceacam1/ mice (KO) reintroduced with empty vector (emp), CEACAM1-2L (CC1-2L), CEACAM1-4L (CC1-4L),
CEACAM1-2S (CC1-2S), CEACAM1-4S (CC1-4S), ITIMs mutated CEACAM1-2L (CC1-2Lm), and ITIMs mutated CEACAM1-4L (CC1-4Lm).
(B) Methylcellulose colony formation assay of 13 105 BM cells from Ceacam1/ (KO) with empty vector (emp), CC1-2L, CC1-4L, CC1-2S, CC1-4S, CC1-2Lm,
and CC1-4Lm chimeras in response to G-CSF (100 ng/ml; mean ± SEM, n = 6 mice).
(C) Immunoblot analysis of p-Stat3 and Stat3 in Ceacam1/ mice (KO) with empty vector (emp), CC1-2L, CC1-4L, CC1-2S, CC1-4S, CC1-2Lm, and CC1-4Lm
Lin BM cells with or without G-CSF treatment (40 ng/ml). Numbers below lanes indicate ratio of p-Stat3 to GAPDH.
(D) Immunoblot analysis of the p-Tyr, G-CSFR, SHP-1, and CEACAM1 in Ceacam1/ mice (KO) with empty vector (emp), CC1-2L, CC1-4L, CC1-2S, CC1-4S,
CC1-2Lm, and CC1-4Lm Lin BM cells with or without G-CSF treatment (40 ng/ml) after IP with CC1 antibody.
(E) Immunoblot analysis of G-CSFR and SHP-1 in WT and Ceacam1/ Lin BM cells with or without G-CSF treatment (40 ng/ml) after IP with anti-SHP-1.
(F) Immunoblot analysis of p-Tyr and G-CSFR in WT and Ceacam1/ Lin BM cells with or without G-CSF treatment (40 ng/ml) after IP with anti-G-CSFR.
*p < 0.05; **p < 0.005 (two-tailed Student’s t test).
Data are representative of three experiments (A, C, D, E, and F).
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Figure 5. Ceacam1–/– Mice Are Hypersensi-
tive to Listeria Monocytogenes Infection
(A) Survival of WT and Ceacam1/ mice (KO)
(n = 12 per group) after LM infection (i.p. injection
of 2.5 3 105 CFUs per mouse).
(B) LM colony number in the liver and spleen of WT
and Ceacam1/ mice 72 hr postinfection (n = 8
per group).
(C) H&E staining showing liver sections from WT
and Ceacam1/ mice 72 hr postinfection. Note
the severe tissue damage and necrosis (see high
magnification) in the liver from Ceacam1/ mice.
(D) Total number of neutrophils (Ly-6G+,CD11b+),
monocytes (Ly-6C+,CD11b+), and macrophages
(Ly-6C,CD11b+,F4/80+) recovered from livers of
WT and Ceacam1/ mice 72 hr postinfection
(mean ± SEM, n = 8 mice).
(E) Serum amounts of IL-1b, IL-6, TNF-a, and
KC from WT and Ceacam1/ mice 24 hr after
infection (mean ± SEM, n = 8 mice). *p < 0.05;
**p < 0.005 (two-tailed Student’s t test).
Immunity
CEACAM1 Regulation of Granulopoiesisexhibited similar serum amounts of TNF-a, IL-6, and KC as
Ceacam1/ mice (Figure S5C) and had a similar degree of liver
damage (Figure S5D, quantified in Figure S5E), both of which
were probably because of the abnormal number of neutrophils.
However, their serum amount of IL-1b was dramatically lower
than inCeacam1/mice,and theG-CSFtreatedWTmiceshowed
better survival than Ceacam1/ mice (Figure S5F). Although the
G-CSF treated WT mice had better bacterial clearance than
untreatedWTmice (data not shown), they showed poorer survival
than theWTmice (Figure S5F), which could be because of the liver
damage and elevated cytokine amounts as shown above, consis-
tent with previous studies showing G-CSF treatment potentiated
neutrophil-induced tissue damage and proinflammatory response
(Croker et al., 2004; Roberts et al., 1997).
These results also indicated that the hypersensitivity of
Ceacam1/ mice to LM infection was not solely because of
the increased number of neutrophils, but was partially because
of elevated proinflammatory cytokine amounts, especially
IL-1b. Based on these findings, we conclude that the combina-
tion of severe liver damage and high proinflammatory cytokine
amounts induced accelerated mortality of LM infected
Ceacam1/ mice.
We also studied LM infected Ceacam1/ mice reconstituted
with CEACAM1-2L, CEACAM1-4L CEACAM1-2S, CEACAM1-
4S, CEACAM1-2Lm, CEACAM1-4Lm, or empty vector trans-
duced Ceacam1/ BM cells. As expected, only CEACAM1-2L
orCEACAM1-4L rescuedCeacam1/mice fromhypersensitivity626 Immunity 33, 620–631, October 29, 2010 ª2010 Elsevier Inc.toLM infection (Figure6A),withmanifesta-
tionofgreatly less liverdamage (Figure6B,
quantified in Figure S5G) and lower serum
cytokine amounts (Figure 6C).
Reduction of Stat3 with shRNA
Restores Normal Granulopoiesis
and Attenuates Host Sensitivity
to LM Infection of Ceacam1–/–Mice
To confirm that elevated G-CSFR-Stat3
signaling was responsible for enhancedgranulopoiesis and the corresponding hypersensitivity to LM
infection of Ceacam1/ mice, we reduced Stat3 amounts with
Stat3 shRNA in Ceacam1/ BM cells followed by reinjection
into lethally irradiated Ceacam1/ mice. Two months after BM
reconstitution, we found that reduction of Stat3 amounts by
shRNA completely restored normal granulopoiesis both in vivo
and in vitro (Figures 7A and 7B), as well as normal GMP amounts
(data not shown). Immunoblot analysis showed that the reduc-
tion of total Stat3 in Ceacam1/ Lin BM cells by shRNA was
around 65%, which in turn, reduced p-Stat3, C-Myc, and
CyclinD1 to theWT amounts after G-CSF stimulation (Figure 7C).
In contrast, Stat1 and Stat5 remained weakly phosphorylated
after reduction of total Stat3, confirming that Stat3 plays a domi-
nant role downstream of G-CSFR. shRNA specificity was
confirmed because shStat3 did not affect Stat1 or Stat5
amounts, and the shRNA control did not affect Stat protein
amounts, ruling out the possibility of off-target effects. We then
challenged these mice with LM and examined if normalized
granulopoiesis could rescue the accelerated mortality of
Ceacam1/ mice. Indeed, reduction of Stat3 partially rescued
Ceacam1/ mice from hypersensitivity to LM infection as man-
ifested by prolonged survival (Figure 7D) associated with less
liver damage (Figure 7E, quantified in Figure S6) and lower serum
amounts of IL-6, TNF-a, and KC (Figure 7F). However, IL-1b re-
mained high after reduction of total Stat3 by shRNA (Figure 7F),
a finding that might explain their relatively poorer survival
compared with WT mice, especially at early days postinfection.
Figure 6. Reintroduction of CEACAM1 Long Isoforms Restores Host
Sensitivity to LM Infection
(A) Survival of Ceacam1/mice (KO) with empty vector (emp), CC1-2L, CC1-
4L, CC1-2S, CC1-4S, CC1-2Lm, and CC1-4Lm chimeras (n = 12 per group)
after LM infection (i.p. injection of 2.5 3 105 CFUs per mouse).
(B) H&E staining showing liver sections (see high magnification) from
Ceacam1/ mice (KO) with empty vector (emp), CC1-2L, CC1-4L, CC1-2S,
CC1-4S, CC1-2Lm, and CC1-4Lm chimeras 72 hr postinfection.
(C) Serum amounts of IL-1b, IL-6, TNF-a and KC from Ceacam1/ mice (KO)
with empty vector (emp), CC1-2L, CC1-4L, CC1-2S, CC1-4S, CC1-2Lm, and
CC1-4Lm chimeras 24 hr after infection (mean ± SEM, n = 6 mice). p values
were calculated between groups indicated by bars using one-way ANOVA.
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Although CEACAM1 has been designated as a marker for
neutrophil activation (Singer et al., 2002) and plays a role in
neutrophil apoptosis (Singer et al., 2005), a role for CEACAM1
in granuolopoiesis has not been studied. Here, we showedCEACAM1 is a granulocytic lineage differentiation marker, and
Ceacam1/ mice had severe neutrophilia associated with
hyperproliferation of Ceacam1/ neutrophil progenitor cells.
This finding, together with the general function of CEACAM1 as
an inhibitory coreceptor in T cells (Gray-Owen and Blumberg,
2006), led us to hypothesize that CEACAM1 may downregulate
neutrophil production by acting as a coinhibitory receptor for
G-CSFR, the master regulator of granulopoiesis (Liu et al.,
1996; McLemore et al., 2001). This hypothesis was strengthened
by the finding that in Lin BM cells, G-CSFR was co-IPed with
CEACAM1 when treated with G-CSF and that, under this condi-
tion, CEACAM1 was phosphorylated on its ITIMs and recruited
SHP-1. The recruitment of SHP-1 downregulated G-CSFR
signaling by decreasing the phosphorylation of G-CSFR, attenu-
ating its downstream Stat3 activation and expression of mito-
genic proteins Cyclin D1 and C-Myc, thereby controlling
the proliferation of neutrophil progenitors. In the absence of
CEACAM1 the negative feedback loop would be absent allowing
neutrophil precursors to abnormally produce neutrophils.
The inhibitory activity of CEACAM1 resides in the long iso-
forms that have two ITIMs that, when phosphorylated, recruit
SHP-1 and -2 (Gray-Owen and Blumberg, 2006). Using retroviral
vector transduced BM stem cell-based BM reconstitution
assays, we demonstrated that the CEACAM1 long form was
able to associate with G-CSFR and restore normal granulopoie-
sis and that mutation of the tyrosine residues in its ITIMs
abrogated this restoration. Furthermore, we found that only the
CEACAM1 long forms recruited the suppressive phosphatase
SHP-1 and that SHP-1 antibodies were able to co-IP G-CSFR,
leading to dephosphorylation of activated G-CSFR. We demon-
strated the dependency of SHP-1 in regulating granulopoiesis by
reduction of SHP-1 in WT mice by shRNA, a treatment that also
leads to enhanced G-CSFR-Stat3 signaling and granulopoiesis,
consistent with the previous observation that SHP-1 genetically
ablated mice develop neutrophilia (Kruger et al., 2000). Interest-
ingly, G-CSF also induced tyrosine phosphorylation of the short
isoform, although this isoform did not appear to associate with
SHP-1 or regulate granulopoiesis. This intriguing result leaves
open a role for the tyrosine residue in the murine short form of
CEACAM1, although it is not present in the context of an ITIM.
Notably, the human CEACAM1 short isoform has phenylalanine
in place of tyrosine (Chen et al., 2007). Thus, further studies are
required to determine if the short isoform in murine CEACAM1
has any additional functions upon phosphorylation of its tyrosine
residue.
Stat3, an oncogene in many tumors (Yu et al., 2009), is the
dominant Stat protein downstream of G-CSFR that positively
regulates granulopoiesis (Avalos, 1996). Stat3 also regulates
proliferation of early progenitor cells of granulocytes (Zhang
et al., 2010) and is subject to negative regulation by induction
of SOCS3, a negative feedback loop of Stat signaling (Croker
et al., 2004). As expected, Socs3/ mice have hyper-p-Stat3
and enhanced granulopoiesis (Croker et al., 2004). Similarly,
our study of Ceacam1/ mice serves as another example in
which loss of a negative regulator leads to hyper-p-Stat3 and
hypergranulopoiesis. We examined this further by reducing
Stat3 amounts in Ceacam1/ mice, which, in turn, normalized
p-Stat3 amounts and completely restored normal granulopoie-
sis, confirming that hyper-p-Stat3 was the main factorImmunity 33, 620–631, October 29, 2010 ª2010 Elsevier Inc. 627
Figure 7. shRNA Reduction of Stat3
Restores Normal Granulopoiesis and Atten-
uates Host Sensitivity to LM Infection of
Ceacam1–/– Mice
(A) Flow-cytomteric analysis of Ly-6G+,CD11b+
neutrophils in BM and PB in Ceacam1/ mice
reconstituted with shRNA control retroviral vector
transduced Ceacam1/ (KO) BM cells (sh Ctrl) or
sh Stat3 retroviral vector transduced Ceacam1/
(KO) BM cells (sh Stat3) compared with
Ceacam1/ BM (KO).
(B) Methylcellulose colony formation assay of 1 3
105 BM cells from Ceacam1/ mice (KO) trans-
duced with shRNA control vector (sh Ctrl) or sh
Stat3 vector (sh Stat3) in response to varying
concentrations of G-CSF (mean ± SEM, n = 6
mice).
(C) Upper: immunoblot analysis of p-Stat3, Stat3,
p-Stat1, Stat1, p-Stat5, and Stat5 in Ceacam1/
mice (KO) with sh control (sh Ctrl) or sh Stat3
(shStat3) Lin BM cells with or without G-CSF
treatment (40 ng/ml). Numbers below lanes
indicate the ratio of p-Stat3 or Stat3 to GAPDH.
Lower: immunoblot analysis of C-Myc and Cy-
clinD1 in Ceacam1/ mice (KO) with sh control
(sh Ctrl) or sh Stat3 (sh Stat3) Lin BM cells with
or without G-CSF treatment (40 ng/ml).
(D) Survival of Ceacam1/ mice (KO) with sh
control (sh Ctrl) or sh Stat3 (shStat3) Lin BM cells
(n = 12 per group) after LM infection (i.p. injection
of 2.5 3 105 CFUs per mouse).
(E) H&E staining showing liver sections (tissue
damage and necrosis as shown in high magnifica-
tion) from Ceacam1/ mice (KO) with sh control
(sh Ctrl) or sh Stat3 (shStat3) Lin BM cells 72 hr
postinfection.
(F) ELISA measurement of serum amounts of
IL-1b, IL-6, TNF-a, and KC from Ceacam1/
mice (KO) with sh control (sh Ctrl) or sh Stat3
(shStat3) Lin BM cells 24 hr after infection
(mean ± SEM, n = 6 mice). *p < 0.05; **p < 0.005;
***p < 0.0001 (two-tailed Student’s t test).
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CEACAM1 Regulation of Granulopoiesisresponsible for neutrophilia in Ceacam1/ mice. Notably, Stat3
also antagonizes Stat1 and Stat5 activation (Lee et al., 2002),
which explains the weak activation of Stat1 and Stat5 in
response to G-CSF in Stat3-proficient models (Avalos, 1996;
Chakraborty et al., 1996; Tian et al., 1994), while loss of Stat3
leads to alternative Stat1 hyperactivation, which, in turn,
compensates for Stat3 and causes neutrophilia (Lee et al.,
2002). Although these investigators interpret these results as
evidence that Stat3 is a negative regulator of granulopoiesis,
we argue that loss of Stat3 abrogates its normal antagonistic
function on Stat1 and Stat5 signaling.
Similar antagonizing mechanisms occur in T helper (Th) cell
differentiation and activation, where loss of Stat3 leads to628 Immunity 33, 620–631, October 29, 2010 ª2010 Elsevier Inc.augmented Stat1 activation and Th1 cell
response (Welte et al., 2003). In the case
of the Stat3 conditional gene ablated
studies (Lee et al., 2002), evidence is
provided that Stat3 is a negative regulator
of Stat1 and Stat5 in granulopoiesis, butno evidence is provided that Stat3 is a negative regulator of
granulopoiesis in wild-type or any other Stat3-proficient mice.
In this regard, Stat3-proficient Socs3/ mice (Croker et al.,
2004) are not the equivalent situation to the Stat3 conditionally
ablated mouse model, in which Stat1 mediated enhanced gran-
ulopoiesis (Lee et al., 2002). Although the study of the Socs3/
mice shows the crucial nature of the negative feedback loop
provided by the Stat3 target gene SOCS3, it does not disregard
Stat3’s major function of transcribing mitogenic factors that
positively regulate granulopoiesis. Instead, there is an exagger-
ated outcome demonstrating Stat3’s role as a positive regulator
in the absence of negative regulation. Take together, we can
reconcile these previous studies and summarize Stat3’s function
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CEACAM1 Regulation of Granulopoiesisin G-CSF-mediated granulopoiesis as follows: Stat3 is the domi-
nant Stat protein downstream of G-CSFR, and, when present, it
positively regulates granulopoiesis by promoting mitogenic
signaling. One the one hand, Stat3 is subject to negative regula-
tory mechanisms, including its self-induction of SOCS3, and that
loss of the inhibitory mechanism(s) leads to hyper Stat3 activa-
tion, augmented mitogenic signaling, and enhanced granulopoi-
esis. But on the other hand, Stat3 antagonizes or negatively
regulates Stat1 and Stat5 activation, and when Stat3 is totally
absent, its antagonizing role is lost and Stat1 becomes hyperac-
tive, a result that not only compensates for loss of Stat3 but also
leads to neutrophilia. With this in mind, we gain a fuller appreci-
ation that Stat3 expression and activation must be properly
controlled for normal granulopoiesis.
TheabsenceofCEACAM1 in theCeacam1/micenotonly led
to neutrophilia but also caused a major problem in their in vivo
response to LM infection. Although the surplus of neutrophils
caused enhanced bacteria clearance in the Ceacam1/ mice,
they also induced severe liver damage and elevated serum cyto-
kine amounts, especially IL-1b, leading to accelerated mortality,
especially during the early days in which innate immunity
predominates. Whether there are strain (C57B/6) effects on
G-CSF treatment and LM infection experiment could be tested
in the future when Ceacam1/ mice on other backgrounds are
available. Interestingly, reintroduction of CEACAM1 long form,
but not the short form or ITIMmutated long form, toCeacam1/
mice not only restored normal granulopoiesis but also normalized
amounts of IL-1b, which correspondingly completely restored
normal sensitivity to LM infection, demonstrating a critical check-
point function for CEACAM1. However, it is worth noting that this
checkpoint role is not limited to the G-CSFR-Stat3 pathway of
granulopoiesis because while reduction of total Stat3 amounts
in Ceacam1/ BM by shRNA completely restored normal
granulopoiesis, serum IL-1b amounts remained high. We also
examined whether loss of CEACAM1 affects cellular cytokine
production by stimulating neutrophils and macrophages
in vitro. Althoughnoobviousdifference in thecytokineproduction
between WT and Ceacam1/ macrophages was observed,
Ceacam1/ neutrophils produced slightly more IL-6 and signifi-
cantly more IL-1b production (manuscript in preparation). Why
loss of CEACAM1 preferably affects cytokine (IL-1b) production
in neutrophils, but not in macrophages, remains an open ques-
tion. Thus, our studies reveal CEACAM1 regulates both the
quantitative and qualitative response of neutrophils to infection.
In summary, CEACAM1 provides a critical negative feedback
loop in the regulation of granulopoiesis and the corresponding
innate immune response to infections, demonstrating the ‘‘fine
tuning’’ of the innate immune system by a coinhibitory receptor.
These insights should help us better understand the interactions
between cell surface receptors orchestrating innate immune
system development and may have clinical implications in treat-
ing infectious, autoinflammatory, and other innate immunity-
related diseases.EXPERIMENTAL PROCEDURES
Mice Strains
Ceacam1/ mice (C57B/6 background) were generated by Beauchemin and
coworkers (Hemmila et al., 2004). C57BL/6 mice were from National CancerInstitute and congenic CD45.1 C57B/6 mice were from The Jackson Labora-
tory. Seven- to twelve-week-old mice were used for all the experiments. To
induce emergent granulopoiesis, G-CSF (2.5 ug/mouse, twice a day) was
injected intraperitoneally (i.p.) into mice for 5 consecutive days.
Listeria Monocytogenes Infection and Colony Counting
ListeriaMonocytogenes EGD (ATCC) were cultured overnight in DIFCO Listeria
Enrichment Broth (BD Biosciences). Colony-forming units (CFUs) of LM were
determined by plating serial dilutions of LM on BBL CHROMagar Listeria
plates (BD Biosciences). 2.5 3 105 CFUs of LM were injected i.p. into mice.
Twenty-four hours later, peripheral blood was collected for cytokine amounts.
Seventy-two hours later, livers and spleens were collected for histology and
measurement of bacterial colony numbers 48 hr after plating.
Quantitative Real-Time PCR
RNA extractions were performed with Trizol (Invitrogen). Reverse transcription
was performed (QIAGEN) by real-time on a Bio-Rad IQ5. CEACAM1 isoforms,
Cyclin D1, and C-Myc mRNA expression was normalized to HPRT. Primer
sequences will be provided upon request.
Construction and Generation of Retroviral Vectors
CEACAM1-2L, 4L, 2S, or 4S cDNAs were cloned into retroviral vector
(MSCV-EGFP). The ITIM mutations on CEACAM1-2L and -4L were generated
using QuikChange XL Site-Directed Mutagenesis Kit (Stratagene) The
shRNA control vector, shStat3 vector (pGFP-V-RS) and Sh SHP-1 vector
(pGFP-V-RS) were from Origene, and the target sequence of shStat3 vector
is 50- AGTTCCTGGCACCTTGGATTGAGAGTCAA-30 and the target sequence
of shSHP-1 vector is 50- TTGTGCGTGAGAGTCTCAGCCAACCTGGT-30. All
retroviral vectors were generated in Phoenix-Eco packaging cell line. For
MSCV-EGFP-based vectors, viral titers of the supernatants from the stable
virus-producing cells were determined in NIH 3T3 cells by flow cytometry.
Primer sequences will be provided upon request.
Bone Marrow Reconstitution Assays
For reverse BM reconstitution assays, 7-week-old WT or Ceacam1/ mice
were lethally irradiated with 1000 Gy, and 53 106Ceacam1/ or WT BM cells
were intravenously (i.v.) injected into themice 8 hr after irradiation. Twomonths
later, mice were sacrificed, and the ratio of cell lineages was assessed by flow
cytometry. For BM competition assays, 7-week-old WT mice were coinjected
with equivalent (13 106)Ceacam1/ (CD45.2) and congenicWT (CD45.1) BM
cells after lethal irradiation.
Retroviral Transduction of Bone Marrow Stem Cells
5-Fluorouracil (5 mg/mouse) was injected i.p. into Ceacam1/ mice and BM
stem cells were collected 5 days later and expanded in 10% FBS DMEM
plus 20 ng/ml IL-3, 50 ng/ml IL-6, and SCF for 24 hr. Viral-based empty vector,
CEACAM1-2L, -4L, -2S, -4S, -2Lm, and -4Lm transduced cells were sorted
48 to 72 hr later as GFP-positive cells. Viral-expressed shRNA control vector,
shStat3 vector, and shSHP-1 vector were selected with puromycin (1 mg/ml)
7 days later. Collected cells were injected i.v into lethally irradiated
Ceacam1/ recipients (1–5 3 105 cells/mouse) and phenotyped 2 months
later.
Cell Sorting and Flow-Cytometric Analysis
Lineage-negative BM (Lin BM) cells were purified using antibody-magnetic
bead depletion (Zhu et al., 2009). Neutrophils (Ly-6G+CD11b+) were labeled
with FITC or PE-Cy5-conjugated anti-Ly-6G, APC-Cy7-conjugated anti-
mouse CD11b. Monocytes (Ly-6C+CD11b+) were labeled with PE-conjugated
anti-mouse Ly-6C, APC-Cy7-conjugated anti-mouse CD11b, and macro-
phages (Ly-6CCD11b+F4/80+) were labeled with PE-conjugated anti-mouse
Ly-6C, APC-Cy7-conjugated anti-mouse CD11b, and APC-conjugated F4/80.
GMP, CMP, and MEP, Lin BM cells were labeled with FITC-conjugated
anti-CD16-32, APC-conjugated or PE-Cy5 conjugated anti-CD34, PE-Cy7-
conjugated anti-Sca-1, PE-conjugated anti-IL-7Ra, and APC-Cy7-conjugated
anti-C-kit. Cells were permeabilized (BD Cytofix/Cytoperm) for intracellular
staining of p-Stat3 and Stat3 on a FACS Canto II (BD Biosciences).Immunity 33, 620–631, October 29, 2010 ª2010 Elsevier Inc. 629
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BrdU was injected i.p into mice immediately followed by i.p. injection of LPS
(25 mg/kg) or PBS. Six hours later, mice were sacrificed and GMPs were
labeled as described above. BrdU was detected with APC-conjugated
antibody from BD.
Methylcellulose Colony-Forming Assays
5 3 104 Lin BM cells were cultured in Methylcellulose media supplemented
with 20 ng/ml G-CSF, 20 ng/ml GM-CSF, 10 ng/ml SCF, 15 ng/ml EPO,
and 10 ng/ml TPO (Sigma). After incubating at 37C 5% CO2 for 10 days,
granulocyte colony numbers were counted according to corresponding
morphologies.
Immunoblot, Immunoprecipitation, and ELISA
Linmyeloid progenitors (53 106) with or without G-CSF treatment were lysed
using RIPA buffer (Sigma) supplemented with 4 mM Na3VO4, 50 mM NaF and
1mMPMSF. Total cell extracts were examined by IP and immunoblot analysis
using corresponding antibodies for specific proteins as previously described
(Chen and Shively, 2004). IL-1b, IL-6, KC, and TNF-a serum amounts were
measured with ELISA kits according to manufacturers’ manuals (Biolegend
and R&D Systems).SUPPLEMENTAL INFORMATION
Supplemental information includes six figures and Supplemental Experimental
Procedures and is available online at doi:10.1016/j.immuni.2010.10.009.
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